Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Outline strategies for the treatment of hypertension, hyperlipidemia, ASHD and diabetes, including the use of newer pharmacological agents and lifestyle therapies;

  2. Identify candidates for cardiac resynchronization and wearable versus implantable cardioverter-defibrillator therapies;

  3. Aid gender-specific approaches toward the prevention of cardiovascular health;

  4. Describe current and emerging treatment options for patients with valvular heart disease;

  5. List the latest recommendations for the management of pulmonary embolism, ST and non-ST elevation MI;

  6. Discuss treatment options for the heart failure patient including acute and advanced failure;

  7. Apply knowledge gained in the conference through clinical case review and MOC cases.